1 year return (CAGR)
57.32%
Rapport Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
RAPP
41.47
+1.81 (+4.56%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.99B
Price/Sales
99.48
Ent value
1.96B
Price/Book
4.70
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 39.97 |
| Daily high | 41.55 |
| Daily low | 37.94 |
| Daily Volume | 900K |
| All-time high | 52.50 |
| 1y analyst estimate | 62.05 |
| Beta | 0.97 |
| EPS (TTM) | -2.89 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 17 Mar 2026 |
Downside potential
Loading...
Downside potential data
| RAPP | S&P500 | |
| Current price drop from All-time high | -21.01% | -0.58% |
| Highest price drop | -75.54% | -56.47% |
| Date of highest drop | 3 Mar 2025 | 9 Mar 2009 |
| Avg drop from high | -26.32% | -10.68% |
| Avg time to new high | 19 days | 12 days |
| Max time to new high | 222 days | 1805 days |
News
